Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced new data from the randomized, ...
Understanding the Link Between Gastric Ulcers and Stomach Cancer Risk
As gastroenterology research progresses, it is critical to comprehend the connection between stomach cancer and gastric ...
Armed robbery in Revesby6 T.
Blood Test Guides Drug to Cut Colon Cancer Recurrence
The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III ...
EurekAlert!6 T.
Blood test from Alliance trial guides use of anti-inflammatory drug to lower colon cancer recurrence risk
The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...
Ärzteblatt1 T.
Abelacimab führt bei Vorhofflimmern zu weniger Blutungen als Rivaroxaban
Boston – Monatliche subkutane Injektionen des Antikörpers Abelacimab, der den Gerinnungsfaktor XI neutralisiert, haben in einer Phase-2b-Studie bei ...